發明
美國
14/529,313
US 9,744,146 B2
Method for Alleviating Disturbance of Bile Acid Metabolism,Amino Acid Metabolism,and/or Gut Microbiota Metabolism
中國醫藥大學
2017/08/29
一種用於調節體內代謝紊亂之相關疾病的醫藥組合物及其應用,包括沒食子酸 (五倍子酸, 棓酸, 3,4,5-Trihydroxybenzoic acid, gallate, 149-91-7, Benzoic acid, 3,4,5-trihydroxy-, Gallic acid, tech., 3,4,5-Trihydroxybenzoate, GALOP)、或沒食子酸丙酯 (Propyl Gallate, N-Propyl gallate, 121-79-9, Progallin P, Tenox PG, Propyl 3,4,5-trihydroxybenzoate, Nipagallin P, Gallic acid, propyl ester)、或焦性沒食子酸 (1,2,3-trihydroxybenzene, pyrogallic acid, 1,2,3-benzenetriol, benzene-1,2,3-triol, Fouramine Brown AP, 87-66-1, fourrine PG, fourrine 85),以及適當的醫藥可接受性賦形劑或載劑,該醫藥組合物是用以調節體內代謝紊亂,進而治療或預防代謝紊亂相關疾病。 A pharmaceutical compositions for regulating the metabolic disorders-related diseases and its application. A pharmaceutical compositions include gallic acid (3,4,5-Trihydroxybenzoic acid, gallate, 149-91-7, Benzoic acid, 3,4,5-trihydroxy-, Gallic acid, tech., 3,4,5-Trihydroxybenzoate, GALOP), or gallic acid ester (Propyl Gallate, N-Propyl gallate, 121-79-9, Progallin P , Tenox PG, Propyl 3,4,5-trihydroxybenzoate, Nipagallin P, Gallic acid, propyl ester), or the focus of gallic acid (1,2,3-trihydroxybenzene, pyrogallic acid, 1,2,3-benzenetriol, benzene-1 ,2,3-triol, Fouramine Brown AP, 87-66-1, fourrine PG, fourrine 85), and the appropriate pharmaceutically acceptable veicle or carrier. The pharmaceutical compositions are used to regulate body metabolic disorders, thereby treating or preventing metabolic disorders-related diseases.
產學合作處生物科技發展育成中心
(04)2205-3366轉1581
版權所有 © 國家科學及技術委員會 National Science and Technology Council All Rights Reserved.
建議使用IE 11或以上版本瀏覽器,最佳瀏覽解析度為1024x768以上|政府網站資料開放宣告
主辦單位:國家科學及技術委員會 執行單位:台灣經濟研究院 網站維護:台灣經濟研究院